Richard R. Furman, M.D.
Richard R. Furman, M.D.
Locations and Appointments
Please contact the doctor's office to verify that your insurance is accepted.
*Indicates this doctor is no longer accepting new patients with this insurance plan.
- HMO
- Medicare
- PPO
- EPO/POS
- CHP
- Blue Access
- Blue Connection
- EPO
- HMO
- Mediblue (Senior)
- PPO
- CBP
- Medicaid
- Medicare
- Freedom
- Liberty
- Medicare Advantage
- Metro/Core/Charter
- Community Plan
- Medicare
- HMO
- Medicare
About Richard R. Furman, M.D.
Dr. Furman is Director of the CLL Research Center at ÈÕ±¾avÉ«ÇéƬ and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
For More Videos, please see below:
Charles, Lillian and Betty Neuwirth Clinical Scholar Award, 2004-2006
-
M.D.Mount Sinai School of Medicine1993
-
Attending PhysicianNewYork-Presbyterian Hospital
-
Professor of MedicineÈÕ±¾avÉ«ÇéƬ Medical College, Cornell University
-
Morton Coleman, M.D. Distinguished Professor of MedicineÈÕ±¾avÉ«ÇéƬ Medical College, Cornell University
-
Associate Attending PhysicianNewYork-Presbyterian Hospital
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.